Dr. Athanasios Maras is trained as general psychiatrist, child and adolescent psychiatrist and psychotherapist in the Central Institute of Mental Health in Mannheim, Germany. In this period he was supervised by Prof. Dr. Drs. multi h.c. Heinz Häfner and by Prof. Dr. Wagner Farid Gattaz.
Since 1997 he is the Director of the Yulius Academy, Institute for Research, Innovation and Education of Yulius Mental Health Organization located in the South-West of the Netherlands. Next to his responsibility for more than 20 current research and innovation projects in child and adolescent psychiatry, he is one of the leaders of a European Research program (Milestone) studying the transition of young people from child to adult mental health services. He published many research articles and book(chapters) and is reviewer of several international journals.
Dr. Maras is awarded with the ABC Schizophrenia award and several poster awards. In 2015 he received a prestigious award in Brazil for his important contribution to the development of child mental health in Campinas.
State-of-the art treatment of sleep disorders in children with autism spectrum disorder
Sleep problems are highly prevalent among children with autism spectrum disorder (ASD), and these problems can significantly impact both the child and the child’s family. Sleep problems have a peak onset at the age of 2 years and include prolonged sleep latency, decreased sleep efficiency, reduced total sleep time, increased waking, bedtime resistance and daytime sleepiness. Sleep disorders in ASD may lead to exacerbations of severity of core ASD symptoms and other maladaptive behaviour. Sleep disorders associated with ASD are often severe and persist throughout the lifespan. As such, these problems can be a major factor in the parent’s decision to place their child with ASD in medical care. Because conventional therapies are generally unsatisfactory, there is a need for new interventions. In this lecture, the aetiology, assessment, potential consequences, and treatment of sleep disorders in children with ASD will be reviewed, with special emphasis on conventional and innovative pharmacological therapies.